East Hanover, NJ, United States of America

Allison Y Luo

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Allison Y Luo

Introduction

Allison Y Luo is a prominent inventor based in East Hanover, NJ (US). She has made significant contributions to the field of medical research, particularly in the treatment of diseases related to Interferon gamma inducible protein 10 (IP-10). Her innovative approach has led to the development of a unique method for administering anti-IP-10 antibodies.

Latest Patents

Allison Y Luo holds a patent for her invention titled "IP-10 antibody dosage escalation regimens." This patent outlines a method for treating IP-10-related diseases by administering a predetermined dosage of an anti-IP-10 antibody. The process includes detecting the antibody levels in the subject and adjusting the dosage accordingly to ensure effective treatment. This innovative method has the potential to improve patient outcomes significantly.

Career Highlights

Allison is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research and development efforts. Her work has been instrumental in exploring new therapeutic avenues for diseases linked to IP-10. With her expertise, she has contributed to the company's mission of discovering and developing innovative medicines.

Collaborations

Allison collaborates with several talented professionals in her field, including Wendy L Trigona and Jinshan Shen. These collaborations enhance the research efforts and foster a dynamic environment for innovation.

Conclusion

Allison Y Luo's contributions to the field of medical research exemplify the impact of innovative thinking in developing effective treatments. Her patent on IP-10 antibody dosage escalation regimens showcases her commitment to improving patient care through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…